GovWire

Research: ACRE advice: application for a vaccine trial of genetically modified Respiratory Syncytial Virus (24/R56/01)

Advisory Committee On Releases To The Environment

May 10
15:30 2024

These documents are the advice of the Advisory Committee on Releases to the Environment (ACRE) to government on an application from Sanofi Pasteur, Inc. to carry out a vaccine trial of genetically modified Respiratory Syncytial Virus.

The committee advised that the risks to human health and the environment from this trial are extremely low.

Published 10 May 2024

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: